These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21210502)

  • 1. Increased survival of free fat grafts and vascularization in rats with local delivery of fragmin/protamine microparticles containing FGF-2 (F/P MP-F).
    Nakamura S; Ishihara M; Takikawa M; Murakami K; Kishimoto S; Nakamura S; Yanagibayashi S; Mori Y; Fujita M; Kubo S; Yamamoto N; Kiyosawa T
    J Biomed Mater Res B Appl Biomater; 2011 Feb; 96(2):234-41. PubMed ID: 21210502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
    Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
    J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of inbred adipose-derived stromal cells in rats with plasma gel containing fragmin/protamine microparticles and FGF-2.
    Sumi Y; Ishihara M; Kishimoto S; Takikawa M; Doumoto T; Azuma R; Nakamura S; Hattori H; Fujita M; Kiyosawa T
    J Biomed Mater Res B Appl Biomater; 2013 Jul; 101(5):784-91. PubMed ID: 23359413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system.
    Nakamura S; Ishihara M; Takikawa M; Kishimoto S; Isoda S; Fujita M; Sato M; Maehara T
    Tissue Eng Part A; 2012 Nov; 18(21-22):2239-47. PubMed ID: 22655590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-rich plasma (PRP) promotes survival of fat-grafts in rats.
    Nakamura S; Ishihara M; Takikawa M; Murakami K; Kishimoto S; Nakamura S; Yanagibayashi S; Kubo S; Yamamoto N; Kiyosawa T
    Ann Plast Surg; 2010 Jul; 65(1):101-6. PubMed ID: 20548232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2-containing low-molecular-weight heparin (Fragmin)/protamine nanoparticles.
    Takikawa M; Nakamura S; Ishihara M; Takabayashi Y; Fujita M; Hattori H; Kushibiki T; Ishihara M
    J Surg Res; 2015 Jun; 196(2):247-57. PubMed ID: 25864985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion and characterization of human bone marrow-derived mesenchymal stem cells cultured on fragmin/protamine microparticle-coated matrix with fibroblast growth factor-2 in low serum medium.
    Kishimoto S; Hattori H; Nakamura S; Amano Y; Kanatani Y; Tanaka Y; Mori Y; Harada Y; Tagawa M; Ishihara M
    Tissue Eng Part C Methods; 2009 Sep; 15(3):523-7. PubMed ID: 19191666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
    Nakamura S; Kanatani Y; Kishimoto S; Nakamura S; Ohno C; Horio T; Masanori F; Hattori H; Tanaka Y; Kiyosawa T; Maehara T; Ishihara M
    J Biomed Mater Res A; 2009 Dec; 91(3):814-23. PubMed ID: 19051304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles.
    Takikawa M; Nakamura S; Nakamura S; Nambu M; Ishihara M; Fujita M; Kishimoto S; Doumoto T; Yanagibayashi S; Azuma R; Yamamoto N; Kiyosawa T
    J Biomed Mater Res B Appl Biomater; 2011 May; 97(2):373-80. PubMed ID: 21432994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization.
    Nakamura S; Kishimoto S; Nakamura S; Nambu M; Fujita M; Tanaka Y; Mori Y; Tagawa M; Maehara T; Ishihara M
    J Biomed Mater Res A; 2010 Mar; 92(4):1614-22. PubMed ID: 19437440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective wound healing in streptozotocin-induced diabetic rats by adipose-derived stromal cell transplantation in plasma-gel containing fragmin/protamine microparticles.
    Sumi Y; Ishihara M; Kishimoto S; Takikawa M; Hattori H; Takikawa M; Azuma R; Nakamura S; Fujita M; Kiyosawa T
    Ann Plast Surg; 2014 Jan; 72(1):113-20. PubMed ID: 24317245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular weight heparin protamine complex augmented the potential of adipose-derived stromal cells to ameliorate limb ischemia.
    Kishimoto S; Inoue K; Nakamura S; Hattori H; Ishihara M; Sakuma M; Toyoda S; Iwaguro H; Taguchi I; Inoue T; Yoshida K
    Atherosclerosis; 2016 Jun; 249():132-9. PubMed ID: 27100923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased free fat-graft survival with the long-term, local delivery of insulin, insulin-like growth factor-I, and basic fibroblast growth factor by PLGA/PEG microspheres.
    Yuksel E; Weinfeld AB; Cleek R; Wamsley S; Jensen J; Boutros S; Waugh JM; Shenaq SM; Spira M
    Plast Reconstr Surg; 2000 Apr; 105(5):1712-20. PubMed ID: 10809102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragmin/protamine microparticle carriers as a drug repositioning strategy for cell transplantation.
    Yeo JE; Nam BM; Yang W; Jo YH; Lee S; Nemeno JG; Kiml BY; Koh YG; Lee JI
    Transplant Proc; 2013 Oct; 45(8):3122-6. PubMed ID: 24157048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo.
    Kishimoto S; Ishihara M; Nakamura S; Fujita M; Takikawa M; Sumi Y; Kiyosawa T; Sato T; Kanatani Y
    Acta Biomater; 2013 Jan; 9(1):4763-70. PubMed ID: 22935325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery system for autologous growth factors fabricated with low-molecular-weight heparin and protamine to attenuate ischemic hind-limb loss in a mouse model.
    Nakamura S; Takikawa M; Ishihara M; Nakayama T; Kishimoto S; Isoda S; Ozeki Y; Sato M; Maehara T
    J Artif Organs; 2012 Dec; 15(4):375-85. PubMed ID: 22890790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic adipose-derived stem cells promote survival of fat grafts in immunocompetent diabetic rats.
    Zhang J; Bai X; Zhao B; Wang Y; Su L; Chang P; Wang X; Han S; Gao J; Hu X; Hu D; Liu X
    Cell Tissue Res; 2016 May; 364(2):357-67. PubMed ID: 26662284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization, stabilization, and activation of human stem cell factor (SCF) on fragmin/protamine microparticle (F/P MP)-coated plates.
    Kishimoto S; Oonuma F; Nakamura S; Hattori H; Nakamura S; Mori Y; Tanaka Y; Harada Y; Tagawa M; Ishihara M
    J Biomed Mater Res B Appl Biomater; 2010 Jan; 92(1):32-9. PubMed ID: 19637375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-Site Preconditioning with Deferoxamine Increases Fat Graft Survival by Inducing VEGF and Neovascularization in a Rat Model.
    Kim J; Park M; Jeong W; Lee HW; Lee G; Suk Lee K; Park SW; Choi J
    Plast Reconstr Surg; 2019 Oct; 144(4):619e-629e. PubMed ID: 31568298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media.
    Kishimoto S; Nakamura S; Nakamura S; Kanatani Y; Hattori H; Tanaka Y; Harada Y; Tagawa M; Mori Y; Maehara T; Ishihara M
    Artif Organs; 2009 Jun; 33(6):431-8. PubMed ID: 19473138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.